Who is sponsoring NCT06167122?

NCT06167122 is sponsored by Chang Gung Memorial Hospital.

What drugs are being tested in NCT06167122?

Interventions in NCT06167122: Craniofacial reconstruction.

What condition does NCT06167122 study?

NCT06167122 studies Craniofacial Fibrous Dysplasia.

Is NCT06167122 still recruiting?

NCT06167122 is currently completed. Last updated 12 December 2023.

Last reviewed 2023-12-12 · How we verify

NCT06167122: CFD

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Treatment Protocol and Long-Term Outcomes in Craniofacial Fibrous Dysplasia

Completed Last updated 12 December 2023

What this trial tests

trial testing Craniofacial reconstruction in Craniofacial Fibrous Dysplasia in 13 participants. Completed in 14 March 2021.

Timeline

1 March 2020

Primary endpoint
10 February 2021

14 March 2021

Quick facts

Lead sponsor	Chang Gung Memorial Hospital
Status	Completed
Study type	OBSERVATIONAL
Enrollment	13
Start date	1 March 2020
Primary completion	10 February 2021
Estimated completion	14 March 2021
Sites	1 location across Taiwan

Drugs / interventions tested

Craniofacial reconstruction

Conditions studied

Craniofacial Fibrous Dysplasia — all drugs for Craniofacial Fibrous Dysplasia →

Sponsor

Chang Gung Memorial Hospital

Who can join

Eligibility, any sex, with Craniofacial Fibrous Dysplasia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Craniofacial fibrous dysplasia (CFD) is a nonneoplastic disease characterized by fibro-osseous lesions in the affected bones. Treatment is mainly surgical and is stratified based on four different anatomical zones. This study aimed to evaluate the long-term outcomes and refine the algorithm for CFD.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Chang Gung Memorial Hospital trials

Trials by the same sponsor.

NCT07419789 — Precision Care for Older Persons · NA · not yet recruiting
NCT07248345 — Virtual Reality Intervention for Family Caregivers of Persons Living With Dementia · NA · not yet recruiting
NCT07036978 — Metabolomic and Immune-Microbiome Profiling for Unresectable Pancreatic Cancer · not yet recruiting
NCT07489833 — Metabolomic Pathways and Traditional Chinese Medicine Body Constitution in Cancer-related Fatigue · not yet recruiting
NCT07496528 — The ACURE Trial: Acupuncture for Colorectal Recovery · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06167122 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Chang Gung Memorial Hospital
Last refreshed: 12 December 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06167122.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing